Hexima Ltd (HXL) - Financial and Strategic SWOT Analysis Review
Hexima Ltd (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Hexima Ltd (Hexima) is a biotechnology company that researches, develops, and commercializes plant-derived proteins and peptides for its applications as human therapeutics. The company utilizes its proprietary technologies such as plant defensin antifungal technology platform and peptide ligation technology for the development of products to find treatments for various fungal/infectious diseases. HXP124, its pipeline drug candidate is being developed for the treatment of fungal nail infections (onychomycosis). The company's operations are mainly in Australia. Hexima is headquartered in Melbourne, Victoria, Australia.
Hexima Ltd Key Recent Developments
Sep 01,2021: Hexima strengthens its board of directors with the appointment of Jake Nunn as Non-Executive Director
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Hexima Ltd (Hexima) is a biotechnology company that researches, develops, and commercializes plant-derived proteins and peptides for its applications as human therapeutics. The company utilizes its proprietary technologies such as plant defensin antifungal technology platform and peptide ligation technology for the development of products to find treatments for various fungal/infectious diseases. HXP124, its pipeline drug candidate is being developed for the treatment of fungal nail infections (onychomycosis). The company's operations are mainly in Australia. Hexima is headquartered in Melbourne, Victoria, Australia.
Hexima Ltd Key Recent Developments
Sep 01,2021: Hexima strengthens its board of directors with the appointment of Jake Nunn as Non-Executive Director
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Hexima Ltd - Key Facts
Hexima Ltd - Key Employees
Hexima Ltd - Key Employee Biographies
Hexima Ltd - Major Products and Services
Hexima Ltd - History
Hexima Ltd - Company Statement
Hexima Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Hexima Ltd - Business Description
Hexima Ltd - SWOT Analysis
SWOT Analysis - Overview
Hexima Ltd - Strengths
Hexima Ltd - Weaknesses
Hexima Ltd - Opportunities
Hexima Ltd - Threats
Hexima Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hexima Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Sep 01, 2021: Hexima strengthens its board of directors with the appointment of Jake Nunn as Non-Executive Director
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Hexima Ltd - Key Facts
Hexima Ltd - Key Employees
Hexima Ltd - Key Employee Biographies
Hexima Ltd - Major Products and Services
Hexima Ltd - History
Hexima Ltd - Company Statement
Hexima Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Hexima Ltd - Business Description
Hexima Ltd - SWOT Analysis
SWOT Analysis - Overview
Hexima Ltd - Strengths
Hexima Ltd - Weaknesses
Hexima Ltd - Opportunities
Hexima Ltd - Threats
Hexima Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hexima Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Sep 01, 2021: Hexima strengthens its board of directors with the appointment of Jake Nunn as Non-Executive Director
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Hexima Ltd, Key Facts
Hexima Ltd, Key Employees
Hexima Ltd, Key Employee Biographies
Hexima Ltd, Major Products and Services
Hexima Ltd, History
Hexima Ltd, Subsidiaries
Hexima Ltd, Key Competitors
Hexima Ltd, Ratios based on current share price
Hexima Ltd, Annual Ratios
Hexima Ltd, Annual Ratios (Cont...1)
Hexima Ltd, Interim Ratios
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hexima Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Hexima Ltd, Key Facts
Hexima Ltd, Key Employees
Hexima Ltd, Key Employee Biographies
Hexima Ltd, Major Products and Services
Hexima Ltd, History
Hexima Ltd, Subsidiaries
Hexima Ltd, Key Competitors
Hexima Ltd, Ratios based on current share price
Hexima Ltd, Annual Ratios
Hexima Ltd, Annual Ratios (Cont...1)
Hexima Ltd, Interim Ratios
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hexima Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Hexima Ltd, Performance Chart (2018 - 2021)
Hexima Ltd, Ratio Charts
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Hexima Ltd, Performance Chart (2018 - 2021)
Hexima Ltd, Ratio Charts
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hexima Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021